Literature DB >> 20395177

Cord blood banking in France: reorganising the national network.

Gregory Katz1, Antonia Mills.   

Abstract

Paradoxically, France is one of the leading exporters of cord blood units worldwide, but ranks only 17th in terms of cord blood units per inhabitant, and imports 64% of cord blood grafts to meet national transplantation demands. With three operational banks in 2008, the French allogeneic cord blood network is now entering an important phase of development with the creation of seven new banks collecting from local clusters of maternities. Although the French network of public banks is demonstrating a strong commitment to reorganise and scale up its activities, the revision of France's bioethics law in 2010 has sparked a debate concerning the legalisation of commercial autologous banking. The paper discusses key elements for a comprehensive national plan that would strengthen the allogeneic banking network through which France could meet its national medical needs and guarantee equal access to healthcare. Copyright 2010. Published by Elsevier Ltd.

Mesh:

Year:  2010        PMID: 20395177     DOI: 10.1016/j.transci.2010.03.002

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  3 in total

1.  Knowledge about umbilical cord blood banking among Greek citizens.

Authors:  Louiza Z Karagiorgou; Maria-Nikoletta P Pantazopoulou; Nikolaos C Mainas; Apostolos I Beloukas; Anastasios G Kriebardis
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  From waste to (fool's) gold: promissory and profit values of cord blood.

Authors:  Jennie Haw
Journal:  Monash Bioeth Rev       Date:  2015-12

3.  Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.

Authors:  Jeremy Magalon; Martin Maiers; Joanne Kurtzberg; Cristina Navarrete; Pablo Rubinstein; Colin Brown; Catherine Schramm; Jérome Larghero; Sandrine Katsahian; Christian Chabannon; Christophe Picard; Alexander Platz; Alexander Schmidt; Gregory Katz
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.